source
- STAT+: The biotech news you need to read todayA Duchenne therapy lawsuit, FDA Commissioner Marty Makary’s White House troubles, and other news from The ReadoutSTAT · 3mo ago↗ source
- Lilly, Gilead lead pharma’s M&A boomDeal volume in 2026 is substantially outpacing last year, and activity is being driven by interest in cancer and autoimmune disease drugs.BioPharma Dive · 3mo ago↗ source
- STAT+: Pharmalittle: We’re reading about an FDA gender rule change, its program for one-day inspections, and moreAn FDA proposal to remove references to “gender” from its regulations sparked concerns about unintended consequences on researchSTAT · 3mo ago↗ source